Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

SRRK

Scholar Rock Holding Corp

Apr 17 • 04:00PM ET

13.70

Dollar change -0.30
Percentage change -2.14	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IBB LABU VTWO SCHA IWC ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.10	Insider Own	23.25%	Shs Outstand	75.98M	Perf Week	-2.28%
Market Cap	1.07B	Forward P/E	-	EPS next Y	-1.83	Insider Trans	30.59%	Shs Float	59.76M	Perf Month	3.79%
Income	-165.79M	PEG	-	EPS next Q	-0.48	Inst Own	89.46%	Short Float	20.95%	Perf Quarter	-12.12%
Sales	0.00M	P/S	-	EPS this Y	1.78%	Inst Trans	-2.51%	Short Ratio	15.90	Perf Half Y	65.86%
Book/sh	2.96	P/B	4.62	EPS next Y	6.34%	ROA	-49.55%	Short Interest	12.52M	Perf Year	72.54%
Cash/sh	3.59	P/C	3.81	EPS next 5Y	-	ROE	-68.30%	52W Range	5.56 - 21.17	Perf YTD	-27.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	8.79%	ROI	-59.57%	52W High	-35.29%	Beta	0.95
Dividend TTM	-	Quick Ratio	8.80	Sales past 5Y	-5.25%	Gross Margin	-	52W Low	146.40%	ATR (14)	1.07
Dividend Ex-Date	-	Current Ratio	8.80	EPS Y/Y TTM	18.42%	Oper. Margin	0.00%	RSI (14)	42.42	Volatility	6.63% 8.10%
Employees	150	Debt/Eq	0.27	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	26.25
Option/Short	Yes / Yes	LT Debt/Eq	0.24	EPS Q/Q	20.09%	Payout	-	Rel Volume	0.96	Prev Close	14.00
Sales Surprise	-	EPS Surprise	-1.46%	Sales Q/Q	-	Earnings	Mar 19 BMO	Avg Volume	787.33K	Price	13.70
SMA20	-9.94%	SMA50	-11.64%	SMA200	16.64%	Trades		Volume	757,851	Change	-2.14%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-28-24	Initiated	Raymond James	Strong Buy	$30
Oct-25-23	Upgrade	Jefferies	Hold → Buy	$20
Apr-03-23	Resumed	Piper Sandler	Overweight	$26
Sep-19-22	Resumed	H.C. Wainwright	Buy	$30
Jul-12-22	Initiated	Truist	Buy	$20
Mar-23-22	Initiated	H.C. Wainwright	Buy	$24
Dec-22-21	Downgrade	Jefferies	Buy → Hold	$52 → $28
Nov-19-21	Initiated	Piper Sandler	Overweight	$56
Apr-26-21	Resumed	Credit Suisse	Outperform	$65
Jan-11-21	Initiated	Credit Suisse	Outperform	$65
Jan-06-21	Initiated	JP Morgan	Overweight	$59
Mar-12-20	Initiated	Robert W. Baird	Outperform	$35

Show Previous Ratings

Apr-12-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.08%
Mar-20-24 05:31AM	Scholar Rock Holding Corp Reports Full Year 2023 Financial Results (GuruFocus.com) +8.58%
Mar-19-24 10:52PM	SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q4 2023 (InvestorPlace) +14.77%
07:00AM	Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress (Business Wire)
Mar-15-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:18AM	Loading…
08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Feb-28-24 08:00AM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire)
Feb-16-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-15-24 08:00AM	Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer (Business Wire)
Feb-06-24 08:00AM	Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management (Business Wire)
Jan-25-24 08:00AM	Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia (Business Wire)
Jan-23-24 08:00AM	Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity (Business Wire)
Jan-22-24 07:00AM	Obesity Drugs Lead to Muscle LossPharma Companies Want to Fix That (The Wall Street Journal)
Jan-18-24 05:01PM	Insider Edward Myles Sells 6,634 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com)
Jan-12-24 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:00AM	Loading…
Jan-04-24 08:00AM	Scholar Rock Provides Corporate Update and Highlights Priorities for 2024 (Business Wire)
Jan-02-24 01:57PM	3 Biotech Stocks at the Forefront of the Quest for Eternal Youth (InvestorPlace) -6.91%
Dec-30-23 07:01PM	Insider Edward Myles Sells 12,459 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com)
Dec-19-23 08:00AM	Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +5.29%
Dec-15-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-10-23 09:05AM	Insider Sell: COO & CFO Edward Myles Sells 24,914 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com)
Nov-17-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-12-23 12:32PM	Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 08:14AM	Scholar Rock Holding Corp (SRRK) Reports Q3 2023 Financial Results (GuruFocus.com)
07:15AM	Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress (Business Wire)
Nov-06-23 09:55AM	Wall Street Analysts See a 99.11% Upside in Scholar Rock Holding Corporation (SRRK): Can the Stock Really Move This High? (Zacks)
Nov-03-23 11:52PM	Insider Sell: Edward Myles Sells 35,007 Shares of Scholar Rock Holding Corp (SRRK) (GuruFocus.com)
04:00PM	Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability (Business Wire)
Nov-02-23 08:00AM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire)
Oct-31-23 08:50AM	Here's Why 'Trend' Investors Would Love Betting on Scholar Rock Holding Corporation (SRRK) (Zacks)
12:00PM	Loading…
Oct-24-23 12:00PM	All You Need to Know About Scholar Rock Holding Corporation (SRRK) Rating Upgrade to Strong Buy (Zacks)
Oct-23-23 08:00AM	Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 (Business Wire)
Oct-19-23 09:55AM	Wall Street Analysts Think Scholar Rock Holding Corporation (SRRK) Could Surge 203.99%: Read This Before Placing a Bet (Zacks)
08:00AM	Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting (Business Wire)
Oct-18-23 08:30AM	Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More (Zacks) -13.56%
Oct-16-23 04:15PM	Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares (Business Wire) +5.36%
Oct-13-23 12:45PM	Scholar Rock (SRRK) Up on Pipeline Advancement, Stock Offering (Zacks)
Oct-12-23 04:17PM	Why Scholar Rock Holding Stock Soared Today (Motley Fool) +17.66%
Oct-11-23 08:57PM	Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock (Business Wire)
05:05PM	Scholar Rock Announces Proposed Public Offering of Common Stock (Business Wire)
04:44PM	Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders (Business Wire)
Sep-19-23 08:00AM	Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial (Business Wire) +10.74%
Sep-15-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-07-23 09:55AM	Wall Street Analysts Believe Scholar Rock Holding Corporation (SRRK) Could Rally 264.53%: Here's is How to Trade (Zacks)
Aug-18-23 04:15PM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-09-23 04:15PM	Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress (Business Wire)
Aug-02-23 10:41AM	Too Cheap to Ignore: J.P. Morgan Says These 2 Stocks Under $10 Could Double Your Money (TipRanks) +6.86%
Jul-13-23 08:00AM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-30-23 11:00AM	New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy (Business Wire) +10.07%
Jun-15-23 08:00AM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-01-23 04:05PM	Scholar Rock to Present at the Jefferies Healthcare Conference (Business Wire)
May-10-23 08:00AM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-09-23 07:30AM	Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress (Business Wire) +5.98%
May-08-23 08:00AM	Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference (Business Wire)
Apr-17-23 12:57PM	Scholar Rock Holding Corporation's (NASDAQ:SRRK) Business Is Trailing The Industry But Its Shares Aren't (Simply Wall St.)
Apr-12-23 08:00AM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-10-23 04:05PM	Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors (Business Wire)
Mar-15-23 08:00AM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-07-23 07:00AM	Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress (Business Wire) +6.55%
Mar-01-23 08:00AM	Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference (Business Wire)
Feb-27-23 08:00AM	Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference (Business Wire)
Feb-17-23 08:00AM	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-11-23 07:23AM	Shareholders in Scholar Rock Holding (NASDAQ:SRRK) have lost 43%, as stock drops 13% this past week (Simply Wall St.)
Feb-06-23 08:00AM	Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer (Business Wire)
Jan-09-23 08:00AM	Scholar Rock Provides Corporate Update and Highlights Priorities for 2023 (Business Wire)
Jan-03-23 08:00AM	Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire) +5.86%
Nov-16-22 06:04AM	Scholar Rock Holding Third Quarter 2022 Earnings: US$0.55 loss per share (vs US$1.02 loss in 3Q 2021) (Simply Wall St.)
Nov-15-22 08:00AM	Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +9.78%
Nov-14-22 08:00AM	Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress (Business Wire)
Nov-10-22 09:00AM	Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy (Business Wire)
Nov-09-22 08:00AM	Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer (Business Wire) -5.90%
Nov-08-22 08:00AM	Scholar Rock to Participate in Upcoming Investor Conferences (Business Wire)
Oct-22-22 07:00AM	New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA (Business Wire)
Oct-06-22 08:00AM	Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting (Business Wire)
Oct-04-22 08:00AM	Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy (Business Wire) +12.41%
Sep-22-22 04:15PM	Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -14.52%
Sep-20-22 07:00AM	Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer (Business Wire)
Sep-19-22 02:39PM	Analyst Builds Bullish Case For This Neuromuscular Company, Sees 200% Upside (Benzinga)
Sep-16-22 08:30AM	Scholar Rock to Present at Upcoming ACCP Annual Meeting and World CB & CDx Summit (Business Wire)
Sep-04-22 08:09AM	Investors in Scholar Rock Holding (NASDAQ:SRRK) have unfortunately lost 75% over the last year (Simply Wall St.)
Aug-08-22 04:15PM	Scholar Rock Reports Second Quarter 2022 Financial Results and Highlights Business Progress (Business Wire)
Jul-25-22 07:14AM	How Many Scholar Rock Holding Corporation (NASDAQ:SRRK) Shares Do Institutions Own? (Simply Wall St.) -10.51%
Jul-19-22 07:30AM	Scholar Rock to Participate in the 2022 Wedbush PacGrow Healthcare Conference (Business Wire) +7.56%
Jul-15-22 08:00AM	Scholar Rock to Present New Preclinical Data on its Targeted Approach to the LTBP-TGF1 Complex for Anti-Fibrotic Therapy at the 2022 FASEB Science Research Conference (Business Wire)
Jul-11-22 09:55AM	Does Scholar Rock Holding Corporation (SRRK) Have the Potential to Rally 246% as Wall Street Analysts Expect? (Zacks)
Jul-01-22 04:00PM	Scholar Rock to Present Phase 3 SAPPHIRE Trial Design at the 17th International Congress on Neuromuscular Diseases (ICNMD 2022) (Business Wire)
Jun-27-22 04:06PM	Why Scholar Rock Stock Flew High Today (Motley Fool) +23.15%
Jun-24-22 09:55AM	How Much Upside is Left in Scholar Rock Holding Corporation (SRRK)? Wall Street Analysts Think 394% (Zacks)
Jun-17-22 11:28AM	Why Scholar Rock Shares Are Trading Higher Today (Benzinga) +10.91%
07:30AM	Scholar Rock Announces $205 Million Registered Direct Offering (Business Wire)
07:00AM	Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA) (Business Wire)
Jun-09-22 04:01PM	Scholar Rock to Present New Apitegromab Data Including 24-Month Efficacy and Safety Data from TOPAZ Phase 2 Trial at the 2022 Annual Cure SMA Conference (Business Wire) -5.85%
Jun-08-22 09:55AM	Wall Street Analysts Think Scholar Rock Holding Corporation (SRRK) Could Surge 413%: Read This Before Placing a Bet (Zacks)
Jun-02-22 07:30AM	Scholar Rock to Present at Jefferies Global Healthcare Conference 2022 (Business Wire)
May-20-22 09:35AM	Down 43.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Scholar Rock Holding Corporation (SRRK) (Zacks)
May-17-22 02:49PM	Muscle disorder biotech to lose 39 employees, chief medical officer (American City Business Journals) +14.97%
12:33PM	Scholar Rock Shares Jumps On Updating Strategic Priorities (Benzinga)
May-16-22 04:15PM	Scholar Rock Reports First Quarter 2022 Financial Results and Updates Strategic Priorities (Business Wire) -6.63%
May-10-22 08:05AM	ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +5.34%
Apr-21-22 07:30AM	Scholar Rock Presents Data Analysis of Multiple Efficacy Endpoints from the Apitegromab TOPAZ Phase 2 Trial at the 2022 European Paediatric Neurology Society Congress (Business Wire) -7.53%

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Backstrom Jay T.	CHIEF EXECUTIVE OFFICER	Feb 16 '24	Sale	15.74	11,614	182,842	352,671	Feb 20 04:46 PM
Myles Edward H	COO & CFO	Feb 16 '24	Sale	15.74	4,744	74,686	210,976	Feb 21 06:13 PM
Parlavecchio Caryn	CHRO	Feb 16 '24	Sale	15.74	3,751	59,053	157,744	Feb 20 04:52 PM
Ho Junlin	GENERAL COUNSEL	Feb 16 '24	Sale	15.74	3,489	54,928	208,771	Feb 20 04:48 PM
Qatanani Mo	CHIEF SCIENTIFIC OFFICER	Feb 16 '24	Sale	15.74	2,512	39,547	147,019	Feb 20 04:58 PM
Myles Edward H	COO & CFO	Jan 16 '24	Sale	15.93	6,634	105,670	162,150	Jan 18 04:07 PM
Ho Junlin	GENERAL COUNSEL	Jan 16 '24	Sale	15.93	4,186	66,677	154,405	Jan 18 04:05 PM
Parlavecchio Caryn	CHRO	Jan 16 '24	Sale	15.93	2,849	45,381	114,350	Jan 18 04:08 PM
Qatanani Mo	SVP AND HEAD OF RESEARCH	Jan 16 '24	Sale	15.93	2,002	31,889	78,816	Jan 18 04:11 PM
Myles Edward H	COO & CFO	Dec 29 '23	Option Exercise	4.86	12,459	60,551	181,243	Dec 29 07:13 PM
Myles Edward H	COO & CFO	Dec 29 '23	Sale	18.83	12,459	234,633	168,784	Dec 29 07:13 PM
Qatanani Mo	SVP AND HEAD OF RESEARCH	Dec 14 '23	Option Exercise	10.00	8,437	84,370	105,480	Dec 15 04:13 PM
Qatanani Mo	SVP AND HEAD OF RESEARCH	Dec 14 '23	Sale	18.18	24,662	448,444	80,818	Dec 15 04:13 PM
Myles Edward H	COO & CFO	Dec 07 '23	Option Exercise	4.86	24,914	121,082	193,698	Dec 08 04:12 PM
Myles Edward H	COO & CFO	Dec 07 '23	Sale	17.53	24,914	436,820	168,784	Dec 08 04:12 PM
Myles Edward H	COO & CFO	Nov 02 '23	Sale	12.51	35,007	438,039	168,784	Nov 03 06:11 PM
AKKARAJU SRINIVAS	Director	Oct 16 '23	Buy	6.85	2,189,781	15,000,000	6,788,609	Oct 18 05:46 PM
Samsara BioCapital GP, LLC	10% Owner	Oct 16 '23	Buy	6.85	2,189,781	15,000,000	6,788,609	Oct 18 05:44 PM
Invus Public Equities, L.P.	10% Owner	Oct 12 '23	Buy	6.86	2,199,931	15,086,736	11,259,438	Oct 16 05:46 PM
Qatanani Mo	SVP AND HEAD OF RESEARCH	Sep 18 '23	Sale	6.34	1,945	12,331	97,043	Sep 20 07:28 PM
Parlavecchio Caryn	CHRO	Aug 16 '23	Sale	6.83	1,353	9,241	117,199	Aug 18 04:05 PM
Invus Public Equities, L.P.	10% Owner	Apr 28 '23	Buy	6.43	31,557	202,845	9,059,507	May 02 09:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SRRK

Scholar Rock Holding Corp

Upgrade your FINVIZ experience